Jupiter Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.66M Sell
97,809
-1,510,447
-94% -$103M 0.04% 324
2026
Q1
$104M Buy
1,608,256
+38,697
+2% +$2.73M 0.55% 51
2025
Q4
$106M Buy
1,569,559
+768,976
+96% +$51.7M 0.85% 26
2025
Q3
$58.7M Buy
800,583
+129,971
+19% +$8.63M 0.5% 60
2025
Q2
$34.9M Buy
670,612
+610,350
+1,013% +$34.7M 0.29% 115
2025
Q1
$3.85M Buy
+60,262
New +$3.5M 0.04% 302

Other funds holding HALO

Jupiter Asset Management's HALO Position: Q2 2026 in Review

Jupiter Asset Management reduced its Halozyme (HALO) stake by 94% in Q2 2026, selling an estimated $103M and leaving 97,809 shares worth $7.66M. The position accounts for 0.04% of the portfolio, ranked #324.

Jupiter Asset Management first reported a position in HALO in Q1 2025 and has held it in 6 quarters since. The position peaked at $106M in Q4 2025. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Jupiter Asset Management held 97,809 shares of Halozyme worth $7.66M as of Q2 2026.
  • Jupiter Asset Management sold 1,510,447 Halozyme shares in Q2 2026, an estimated $103M.
  • Halozyme made up 0.04% of Jupiter Asset Management's portfolio in Q2 2026, its #324 holding.
  • Jupiter Asset Management first reported a position in Halozyme in Q1 2025 and has held it in 6 quarters since.
  • Jupiter Asset Management's Halozyme position peaked at $106M in Q4 2025.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.